Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 28, 2005; 11(16): 2402-2407
Published online Apr 28, 2005. doi: 10.3748/wjg.v11.i16.2402
Published online Apr 28, 2005. doi: 10.3748/wjg.v11.i16.2402
Table 1 Appearance of the 46 hepatic lesions on contrast-enhanced C3-MODE technology: corresponding to the pathological diagnosis.
| C3-MODE | Pathological diagnosis | |||
| HCC | Metastatic tumor | Hemangioma | Lipid degeneration | |
| HCC | 27 | 0 | 1 | 0 |
| Metastatic tumor | 0 | 5 | 0 | 0 |
| Hemangioma | 0 | 1 | 9 | 3 |
Table 2 Ability of differential diagnosis of malignant or benign lesions in liver: comparison between contrast-enhanced C3-MODE technology and contrast-enhanced CT.
| Pathological diagnosis | Sensitivity | Specificity | Accuracy | |||
| Malignant | Benign | |||||
| C3-MODE | Malignant | 32 | 1 | 97.0% | 92.3% | 95.7% |
| Benign | 1 | 12 | ||||
| CT | Malignant | 32 | 2 | 94.1% | 91.7% | 93.5% |
| Benign | 1 | 11 | ||||
| Total | 33 | 13 | ||||
- Citation: Luo BM, Wen YL, Yang HY, Zhi H, Ou B, Ma JH, Pan JS, Dai XN. Differentiation between malignant and benign nodules in the liver: Use of contrast C3-MODE technology. World J Gastroenterol 2005; 11(16): 2402-2407
- URL: https://www.wjgnet.com/1007-9327/full/v11/i16/2402.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i16.2402
